Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amolyt, Astellas, Astrazeneca, Everest, Inventiva, Moderna, RDIF, Redhill, Stealth.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerpio, Aikido, Aim Immunotech, Ana, Asana, ASN, Autolus, Avicanna, Benuvia, Bold, Brickbio, Cristal, Dewpoint, Erasca, Gilead, Intravacc, Iovaxis, Kite, Millendo, Mindset, Neurobo, Nikang, Oxford Biotherapeutics, Pfizer, Radius, Respirex, RDIF, Selecta, Servier, Silo, Targovax, Vaxcyte, Vistagen X-Chem.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Creative Medical, Erasca, Imara, Infinity, Inovio, Millendo, Mycovia, Ocuphire, Regenxbio, Seres, Vir, Windtree, Zentalis.

Biopharmas raising money in public or private financings, including: Aileron, Clearside, Eleva, Eyegate, Histogen, Myeloid, NGM, Revelation, Senti.

New hires and promotions in the biopharma industry, including: Alpine Immune, Artiva, Jnana, Pluristem, Silence, Swanbio, Terns, Verastem.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Arcturus, Astrazeneca, Biocure Technology, Capricor, Celltrion, Hutchison China Meditech, Pharos Vaccine, Tracon.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Arcturus, Direct Biologics, Emergent Biosolutions, Kaleido, Neurorx, Nicox, Ocumension, Redhill, Regeneron, Relief, Sinopharm, Tiziana Life Sciences.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Aivita Biomedical, Arch, Eyepoint, Immvira, Ocumension, Oragenics, Taiwan Liposome, Tracon.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Advaccine Biopharmaceuticals Suzhou, Arcturus, Azurrx, Biontech, Brand Institute, Epivax, First Wave, Generex, Global Cancer Technology, Innovare R&D, Inovio, Moderna, Nugenerex Immuno-Oncology, Pfizer, Pluristem, Propanc, Shanghai Junshi, Vaxil.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: GAO says wound care spending dropped between 2016 and 2018; FDA updates COVID testing data; May 2019 Q-sub guidance appears in final form.